Prevalence of cardiovascular risk and atherosclerotic cardiovascular disease in people with type 2 diabetes in the United Arab Emirates: Results from the prevalence of atherosclerotic cardiovascular disease in patients with type 2 diabetes across Mid
Nearly one-third of T2D patients had eASCVD in UAE, compared to one-fifth in MEA. Most participants were at high or very high risk for ASCVD, but none met all ESC 2021 guidelines, highlighting the need for developing regional strategies to reduce ASCVD risk.
Authors
- Hazem Aly
- Zufana Nazir
- Fatheya Alawadi (ORCID: https://orcid.org/0000-0001-8911-866X)
- Mahir Jallo (ORCID: https://orcid.org/0000-0001-8128-054X)
- Gil Awada (ORCID: https://orcid.org/0000-0001-9535-0430)
- Khadija Hafidh (ORCID: https://orcid.org/0000-0002-3632-4336)
- Jalal Nafach
- Wael Almahmeed (ORCID: https://orcid.org/0000-0003-0312-9910)
- Loai Abudaqa (ORCID: https://orcid.org/0009-0005-7077-3978)
- Hani Sabbour (ORCID: https://orcid.org/0000-0001-6960-1056)
- Fouzia Rashid (ORCID: https://orcid.org/0000-0002-7275-240X)
- Haitham Seifeldin
Institutions
- Dubai Health Authority (AE)
- University of Dubai (AE)
- Gulf Medical University (AE)
- Ajman University (AE)
- Novo Nordisk (Denmark) (DK)
- Brown University (US)
- Oasis Hospital (AE)
- Synergy University Dubai (AE)
- Abu Dhabi Health Services (AE)
Publication Details
- Journal
- Diabetes & Metabolic Syndrome Clinical Research & Reviews
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1016/j.dsx.2025.103224
- Citations
- 3
- Primary Topic
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Type
- article
- Field-Weighted Citation Impact
- 3.88